- Home
- VIVS vs BKYI Comparison
VIVS vs BKYI Comparison
Compare VIVS & BKYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- BKYI
- Stock Information
- Founded
- VIVS 2007
- BKYI 1993
- Country
- VIVS United States
- BKYI United States
- Employees
- VIVS N/A
- BKYI N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- BKYI Computer Software: Prepackaged Software
- Sector
- VIVS Health Care
- BKYI Technology
- Exchange
- VIVS Nasdaq
- BKYI Nasdaq
- Market Cap
- VIVS 4.7M
- BKYI 5.3M
- IPO Year
- VIVS N/A
- BKYI 1997
- Fundamental
- Price
- VIVS $3.19
- BKYI $0.75
- Analyst Decision
- VIVS
- BKYI
- Analyst Count
- VIVS 0
- BKYI 0
- Target Price
- VIVS N/A
- BKYI N/A
- AVG Volume (30 Days)
- VIVS 166.7K
- BKYI 139.1K
- Earning Date
- VIVS 11-07-2025
- BKYI 11-13-2025
- Dividend Yield
- VIVS N/A
- BKYI N/A
- EPS Growth
- VIVS N/A
- BKYI N/A
- EPS
- VIVS N/A
- BKYI N/A
- Revenue
- VIVS $142,000.00
- BKYI $6,911,148.00
- Revenue This Year
- VIVS $42.38
- BKYI $7.45
- Revenue Next Year
- VIVS $15.42
- BKYI $23.29
- P/E Ratio
- VIVS N/A
- BKYI N/A
- Revenue Growth
- VIVS 94.52
- BKYI N/A
- 52 Week Low
- VIVS $1.41
- BKYI $0.52
- 52 Week High
- VIVS $21.96
- BKYI $3.68
- Technical
- Relative Strength Index (RSI)
- VIVS 51.15
- BKYI 46.17
- Support Level
- VIVS $2.90
- BKYI $0.71
- Resistance Level
- VIVS $3.48
- BKYI $0.81
- Average True Range (ATR)
- VIVS 0.34
- BKYI 0.04
- MACD
- VIVS -0.09
- BKYI 0.00
- Stochastic Oscillator
- VIVS 20.86
- BKYI 35.10
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.